Dietary Supplements Blossom As Revenue Growth Ingredients For Big Pharma
This article was originally published in The Tan Sheet
Executive Summary
Dwindling product pipelines are pushing pharmaceutical companies to look to dietary supplements for business opportunities, not only through product sales but also by using herbal substances to develop new drug ingredients
You may also be interested in...
Supplement-To-Drug Applications Look Like The Next Wave To Some Experts
FDA's dietary supplement good manufacturing practices, while imposed to help assure safe nutritionals reach the market, are creating costs that could drive more firms to file new drug applications for natural products, according to a pair of regulatory experts
Supplement-To-Drug Applications Look Like The Next Wave To Some Experts
FDA's dietary supplement good manufacturing practices, while imposed to help assure safe nutritionals reach the market, are creating costs that could drive more firms to file new drug applications for natural products, according to a pair of regulatory experts
Supplement-To-Drug Applications Look Like The Next Wave To Some Experts
FDA's dietary supplement good manufacturing practices, while imposed to help assure safe nutritionals reach the market, are creating costs that could drive more firms to file new drug applications for natural products, according to a pair of regulatory experts